NCT04572451 2025-08-01Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and MelanomaUniversity of PittsburghPhase 1 Recruiting50 enrolled
NCT02904954 2023-10-11Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung CancerWeill Medical College of Cornell UniversityPhase 2 Completed60 enrolled 12 charts